Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Leukemia
November 25, 2019 – Oncology News & Updates
Read More
What Is the Role of Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukemia?
Meg Barbor, MPH
Read More
Meeting Highlights
Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL
Read More
Meeting Highlights
First-Line Acalabrutinib-Based Triplet Therapy Leads to Undetectable Minimal Residual Disease in CLL
Read More
Meeting Highlights
Investigational Oral Form of Azacitidine Improves Survival Maintenance Therapy in Patients with Acute Myeloid Leukemia
Read More
Meeting Highlights
All-Oral Time-Limited Combination Treatment for CLL or SLL Shows Early Impressive Efficacy
Read More
Monitoring Methotrexate Levels in a Patient After Glucarpidase Administration: A Case Report
Savannah L. Gulley, PharmD; Kyle A. Franco, PharmD, BCPPS; Joshua J. Elder, PharmD, BCPS, BCOP
Read More
Venetoclax + Azacitidine versus Azacitidine Alone in Treatment-Naïve Patients with AML Ineligible for Intensive Therapy
Read More
Ivosidenib Improves Overall Survival Relative to Standard Therapies in Relapsed or Refractory IDH1-Mutated AML
Read More
Health-Related Quality of Life with Oral Azacitidine (CC-486) in Patients with Acute Myeloid Leukemia in First Remission After Induction Chemotherapy
Read More
1
2
3
4
5
Page 2 of 7
Results 11 - 20 of 64